Source:http://linkedlifedata.com/resource/pubmed/id/12447174
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0006556,
umls-concept:C0012984,
umls-concept:C0018787,
umls-concept:C0032136,
umls-concept:C0062534,
umls-concept:C0205263,
umls-concept:C0302350,
umls-concept:C0302600,
umls-concept:C0475224,
umls-concept:C0679058,
umls-concept:C1522564,
umls-concept:C1533685,
umls-concept:C1547699,
umls-concept:C2700640
|
pubmed:dateCreated |
2002-11-26
|
pubmed:abstractText |
We investigated the efficacy of directly injecting a plasmid with complementary DNA encoding human hepatocyte growth factor into ischemic canine myocardium to induce angiogenesis.
|
pubmed:language |
eng
|
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:author | |
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1099-105
|
pubmed:dateRevised |
2006-5-1
|
pubmed:articleTitle |
Therapeutic angiogenesis in the ischemic canine heart induced by myocardial injection of naked complementary DNA plasmid encoding hepatocyte growth factor.
|
pubmed:affiliation |
Division of Cardiovascular Surgery, Department of Surgery E1, Osaka University Graduate School of Medicine, Osaka, Japan.
|